Uncategorized

Viridian debuts on market with FDA greenlight for thyroid eye disease drug

Published

on

Viridian Therapeutics’ Lumvoa is the first FDA-approved treatment for thyroid eye disease that includes data for both active and chronic forms of the illness.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version